---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Oral Contraceptives"
developer_entity: "Better Leap Media"
bundle_id: "com.betterleap.OralContPill"
app_store_id: "440954621"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-05-27"
report_date: "2026-04-02"
report_version: "2.18.0"
total_reviews: 5
overall_rating: 4.4
sentiment: "Excited"
sentiment_score: 70
confidence: "medium"
confidence_score: 0.5
data_age_days: 74
intelligence_version: 2
nemesis: "Epocrates"
competitor_count: 10
tags: ["medical", "paid", "excited sentiment", "mobile app", "app review", "app analysis", "medical", "professionals,", "including"]
canonical_url: "https://marlvel.ai/apps/com-betterleap-oralcontpill"
license: "CC-BY-NC 4.0"
last_verified: "2026-04-18T21:08:29.379Z"
---

# Oral Contraceptives App Audit

> **TL;DR:** Oral Contraceptives is a medical app by Better Leap Media, rated 4.4/5 by 5 users, with Excited user sentiment (70/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Oral Contraceptives maintains Excited user sentiment (4.4/5 from 5 reviews), with users consistently praising utility for medical professionals.
<!-- speakable-end -->

## Metadata & Market Performance
- **Publisher:** Better Leap Media
- **Category:** Medical
- **Target Audience:** Medical professionals, including physicians, nurses, and family planning specialists.
- **Platforms:** iOS
- **Version Audited:** 2.18.0
- **Audit Date:** 2026-04-02
- **Signal Count:** 9 reviews analyzed
- **Confidence:** Medium (0.5/1.0)
- **App Store ID (iOS):** 440954621
- **Bundle ID:** com.betterleap.OralContPill
- **Data Window:** Analysis based on signals collected up to 2026-04-02

## Executive Snapshot
The Oral Contraceptives app by Better Leap Media is a specialized clinical reference tool for medical professionals, offering a curated database of over 200 FDA-approved contraceptives. It distinguishes itself through advanced dosage-based filtering and brand-equivalence identification, providing a high-efficiency alternative to broader medical databases.

Despite its age, the app has recently seen a significant surge in visibility, climbing to #18 in its category. However, its long-term viability is threatened by a lack of content updates since 2011, which creates a critical trust gap with its professional user base.

## App DNA (Features & Intent)
- **[Standard] Comprehensive Drug Database:** Access to over 200 FDA-approved name brand and generic oral contraceptives in the U.S. market.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Advanced Filtering:** Filter drugs by estrogen and progestin dosage to find specific formulations.
  * *User Intent:* Users want to quickly find relevant content or features.
- **[Differentiator] Alternative Brand Identification:** Quickly identify equivalent alternative brands for specific contraceptives.

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase of $7.99
- **Price:** iOS: $7.99
- **Analysis:** The app utilizes a straightforward premium model, targeting professionals who value a curated, ad-free, and reliable reference tool over free, potentially unverified sources.

## 🟢 User Sentiment (Medium Confidence: 5 reviews) {#user-sentiment}
- **Overall Rating:** 4.4/5
- **Platform Split:** iOS 4.4/5 (5 ratings)
- **Overall Sentiment:** Excited

### Top Praises
- **Utility for Medical Professionals** | *Evidence:* "As a women’s health NP, I use this app all the time to navigate the endless sea of generic OCPs."

### Top Complaints (Impact Areas)
- **Outdated Content** | *Evidence:* "The app has not been updated since 2011, which makes me wonder if the information is up to date."

## SWOT Analysis

**Core Strengths:**
- Specialized, niche-focused database
- Intuitive dosage-based filtering
- Ad-free premium experience

**Critical Frictions:**
- Lack of updates since 2011
- Limited scope (excludes non-pill methods)
- Low social proof/rating count

**Growth Levers:**
- Expand to include LARCs and other methods
- Transition to subscription for regular updates
- Targeted marketing to medical associations

**Market Threats:**
- Dominance of free, updated competitors
- Clinical liability risks
- Obsolescence of current data

## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Oral Contraceptives vs Epocrates — Head to Head
- **Epocrates** by Epocrates, Inc.: The industry standard for clinical drug reference, offering comprehensive formulary and interaction data that directly competes for the physician's attention.
- **Medscape** by WebMD: Provides a massive, free, and highly updated drug reference database that serves as the primary alternative for medical professionals needing quick clinical information.
- **Lexicomp** by Wolters Kluwer Health: A professional-grade clinical reference tool that offers deep, specialized pharmacological data, often used by the same target audience of clinicians.

### Contenders (Strong Challengers)
- **Drugs.com Medication Guide** by Drugsite, Inc.: Offers a highly reliable, searchable database of FDA-approved drugs that serves as a direct, free alternative for drug identification and information.
- **PDR (Physicians' Desk Reference)** by PDR Network, LLC: Provides authoritative, manufacturer-provided drug information that targets the same professional demographic as the analyzed app.

### Peers (What They Do Better)
- **UpToDate** by Wolters Kluwer Health: The leading clinical decision support resource that, while broader in scope, is the primary tool physicians use for evidence-based practice.
- **DynaMed** by EBSCO Industries, Inc.: A clinical reference tool that provides evidence-based summaries, often used alongside drug databases for patient care decisions.
- **Figure 1** by Figure 1, Inc.: A medical knowledge-sharing platform that occupies the same professional 'Medical' category and targets the same clinical user base.

### New Kids on the Block (What's Innovative)
- **Merck Manual Professional** by Merck Sharp & Dohme Corp.: A high-authority, free, and frequently updated clinical reference that is gaining traction for its accessibility and depth.
- **QxMD Calculate** by QxMD Software, Inc.: A rapidly growing clinical decision support tool that integrates drug information with medical calculators, appealing to modern, efficiency-focused clinicians.

## The "So What?" (Strategic Takeaway) {#so-what}

Oral Contraceptives is a market-leading medical app that is a paid app.
With a 4.4/5 rating from 5 reviews, it delivers strong user satisfaction.

**Strategic Opportunity:** While Oral Contraceptives benefits from specialized, niche-focused database, its vulnerability lies in lack of updates since 2011. A challenger could exploit this by focusing on expand to include larcs and other methods.

**Best for:** Medical professionals, including physicians, nurses, and family planning specialists.

## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.4/5 |
| Total Reviews | 5 |
| Sentiment | Excited (70/100) |
| Confidence | Medium |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 3 analyzed |

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Oral Contraceptives** (this app) | 4.4/5 | Excited | Better Leap Media |
| [Vulvar Pain Algorithm](https://marlvel.ai/apps/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff |
| [Total Reflexology-3D](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion |
| [CardioGenetics](https://marlvel.ai/apps/com-scd-risk-calculator) | N/A/5 | N/A | MARK EMILE PEPIN |
| [ECGsource](https://marlvel.ai/apps/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC |
| [My F1rst Steps](https://marlvel.ai/apps/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC |

## Company Profile
- **Developer:** Better Leap Media
- **Website:** [https://www.contraceptiveapp.com/](https://www.contraceptiveapp.com/)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/oral-contraceptives/id440954621?uo=2)
- **Dev Site:** [Official Website](https://www.contraceptiveapp.com/)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*Vulvar Pain Algorithm*](https://marlvel.ai/apps/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment
- [*Total Reflexology-3D*](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment
- [*CardioGenetics*](https://marlvel.ai/apps/com-scd-risk-calculator) (MARK EMILE PEPIN) — N/A Rating | N/A Sentiment
- [*ECGsource*](https://marlvel.ai/apps/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment
- [*My F1rst Steps*](https://marlvel.ai/apps/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment
- [*Mobile VSO : Claims Guide*](https://marlvel.ai/apps/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment
- [*Pelvic Pain Pentad*](https://marlvel.ai/apps/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment
- [*Protectometer*](https://marlvel.ai/apps/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment
- [*Drug Facts by PillSync.com*](https://marlvel.ai/apps/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment
- [*Beat Social Phobia with AJ*](https://marlvel.ai/apps/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline:

1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning.
2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes.
3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights.

- **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 9
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 74 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-betterleap-oralcontpill)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.